Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-10Clinical Trial Update: Abdominal Binder to Treat Orthostatic Hypotension (OH) in Parkinson's Disease (PD) [Phase 2]
Phase 2 clinical trial evaluating an abdominal binder to treat orthostatic hypotension in Parkinson's disease has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Posiphen® Dose-Finding, Biomarker Study in Early Alzheimer's and Parkinson's Patients [Phase 1, Phase 2]
Phase 1/2 dose-finding biomarker trial of Posiphen in early Alzheimer's and Parkinson's patients completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Effect of SQJZ Herbal Mixtures on Non-motor Symptoms of Parkinson's Disease [Phase 2]
Phase 2 clinical trial investigating SQJZ herbal mixtures for non-motor symptoms in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2023-02-21Clinical Trial Update: Role and Mechanism of Probiotics in Improving Motor Symptoms in Mild to Moderate Parkinson's Disease [Phase 4]
Phase 4 clinical trial update exploring the role and mechanism of probiotics in improving motor symptoms in mild to moderate Parkinson's dis…
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: FitMi PD Home Therapy for Parkinson's Disease [NA]
A completed clinical trial update for FitMi PD Home Therapy in Parkinson's disease with results posted in 2023.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Clinical Study of Stalevo in the Treatment of Early Parkinson's Disease [Phase 4]
A Phase 4 clinical trial update for Stalevo in early Parkinson's disease is listed with unknown status but ongoing investigation.
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations [Phase 3]
Phase 3 study evaluating IPX203 for Parkinson's disease with motor fluctuations has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa [Phase 1, Phase 2]
Phase 1/2 clinical trial update on NE3107 for Parkinson's disease patients using levodopa, evaluating activity and safety.
-
CLINICAL_TRIALS trial_result · 2023-01-25Clinical Trial Update: taVNS in Mild to Moderate Parkinson's Disease [NA]
Completed clinical trial of transcutaneous auricular vagus nerve stimulation (taVNS) in mild to moderate Parkinson's disease with results po…
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Modulation of GABA-A Receptors in Parkinson Disease-Transdermal Flumazenil Arm [Phase 1, Phase 2]
A completed Phase 1/2 trial examining transdermal flumazenil to modulate GABA-A receptors in Parkinson disease; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-12-30Clinical Trial Update: Varenicline for Gait and Balance Impairment in Parkinson Disease [Phase 2]
Phase 2 trial update of varenicline for gait and balance impairment in Parkinson disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-12-16Clinical Trial Update: A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) [Phase 3]
Phase 3 trial update comparing an investigational drug to an approved treatment for Parkinson's disease with motor OFF episodes; study statu…
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: Namenda (Memantine) for Non-motor Symptoms in Parkinson's Disease [Phase 4]
A Phase 4 clinical trial evaluated memantine (Namenda) for non-motor symptoms in Parkinson's disease; study completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease [Phase 3]
Phase 3 open-label continuation study of levodopa-carbidopa intestinal gel in advanced Parkinson's disease has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease [Phase 3]
Phase 3 trial comparing continuous subcutaneous infusion of ABBV-951 with oral carbidopa/levodopa in adults with advanced Parkinson's diseas…
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Cerebellar Transcranial Direct Current Stimulation in Parkinson's Disease [NA]
Completed clinical trial evaluating cerebellar transcranial direct current stimulation in Parkinson's disease; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-31Clinical Trial Update: Vestibular Stimulation in Parkinson's Disease [NA]
Clinical trial on vestibular stimulation for Parkinson's disease has completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: NYX-458 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Parkinson's Disease or Lewy Body Dementia (Cognition, Memory, Attention, Thinking) [Phase 2]
Phase 2 clinical trial update for NYX-458 in subjects with mild cognitive impairment or mild dementia due to Parkinson's disease or Lewy bod…
-
CLINICAL_TRIALS trial_result · 2022-10-10Clinical Trial Update: Study Assessing Efficacy and Safety of AKST4290 in Subjects With Parkinson's Disease on Stable Dopaminergic Treatment [Phase 2]
Phase 2 clinical trial assessing AKST4290 for Parkinson's disease patients on stable dopaminergic therapy has completed and posted results i…
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Trial of Xyrem for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson's Disease (PD) [Phase 2]
Phase 2 trial evaluating Xyrem for excessive daytime sleepiness and sleep disturbance in Parkinson's disease has completed with results post…
-
CLINICAL_TRIALS trial_result · 2022-09-26Clinical Trial Update: TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH) [Phase 2]
Phase 2 clinical trial update for TD-9855 in neurogenic orthostatic hypotension (nOH) completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-09-13Clinical Trial Update: Exenatide Treatment in Parkinson's Disease [Phase 2]
Phase 2 clinical trial investigating exenatide treatment for Parkinson's disease is ongoing, with status currently unknown.
-
CLINICAL_TRIALS trial_result · 2022-09-06Clinical Trial Update: Brain Perfusion & Oxygenation in Parkinson's Disease With NOH [Phase 4]
Phase 4 trial update on brain perfusion and oxygenation in Parkinson's disease with neurogenic orthostatic hypotension has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-12Clinical Trial Update: Acute Effects of Medium Chain Triglyceride (MCT) Nutritional Ketosis on Parkinson's Disease (PD) Symptoms and Biomarkers (MCT-PD) [Phase 1]
Phase 1 study assessing acute effects of medium-chain triglyceride–induced nutritional ketosis on symptoms and biomarkers in Parkinson's dis…
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuse® Delivery System in Parkinson's Disease Patients [Phase 2]
Phase 2 trial evaluating pharmacokinetics, safety, tolerability, and efficacy of continuous oral Levodopa via DopaFuse delivery in Parkinson…